While offering advantages like faster recovery and high patient satisfaction, cryoablation for the treatment of early-stage breast cancer is still under investigation for effectiveness and requires ...

Please provide your email address to receive an email when new articles are posted on . Patients who received cryoablation as treatment for breast cancer had low recurrence rate after 16 months.

The Gauteng MEC for Health & Wellness, Nomantu Nkomo-Ralehoko, announced on X (Twitter) that the Steve Biko Academic Hospital ...

Please provide your email address to receive an email when new articles are posted on . XSense Cryoablation System with CryoProbes is cleared for general minimally invasive cryoablation. The system ...

IceCure Medical Ltd. (NASDAQ:ICCM), the developer of minimally invasive cryoablation technology that destroys tumors by freezing them, was granted marketing authorization from the U.S. Food and Drug ...

Steve Biko Academic Hospital in Pretoria has made history by performing South Africa's first cryoablation procedure, marking a significant advancement in public healthcare and access to innovative ...

CAESAREA, Israel, Oct. 3, 2025 /PRNewswire/ -- The U.S. Food and Drug Administration ("FDA") has granted marketing authorization for ProSense®, a minimally invasive cryoablation treatment for patients ...

Share on Facebook. Opens in a new tab or window Share on Bluesky. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window Women with early ...

The ProSense® Cryoablation System could be a game changer for women over 70 with early-stage, low-risk breast cancer. For decades, breast cancer treatment has often meant surgery, which can be an ...